袖状胃切除术作为肾移植桥接策略的安全性与有效性
本研究为单中心回顾性研究,纳入2013-2018年由多器官移植团队转诊的32例肥胖合并严重慢性肾病(CKD)患者,评估袖状胃切除术(SG)作为肾移植桥接策略的安全性和有效性。主要结局为90天主要并发症,结果显示无漏、无再手术、无死亡,1年BMI变化-9.8 kg/m2,超重体重减少率56%,44%患者成功接受肾移植。结论认为SG在该高危人群中安全有效,可作为桥接手术。
要点
- SG在严重CKD肥胖患者中90天无漏、无再手术、无死亡。
- 1年BMI变化-9.8 kg/m2,超重体重减少率56%。
- 44%患者成功接受肾移植,移植后随访期间无需透析。
核心结论
- SG对严重CKD肥胖患者减重及桥接肾移植候选资格安全有效。
研究设计与样本
- 单中心回顾性研究,前瞻性收集数据库,纳入2013-2018年32例接受SG的肥胖严重CKD患者。
主要发现
- 32例患者中18例(56%)为男性,中位年龄51(11)岁,中位BMI 42.3(5.2)kg/m2。
- 29例(91%)术前透析,中位透析时间28个月。
- 90天内无漏、无再手术、无死亡,中位住院时间2(1.3)天。
- 1年BMI变化-9.8(3.7)kg/m2,超重体重减少率56%(27)。
- SG后1年内20例(63%)进入移植等待名单,14例(44%)成功接受肾移植,1例等待中死亡。
临床怎么用
- 对于肥胖合并严重CKD的肾移植候选者,可考虑SG作为减重和桥接移植的安全手术方式。
局限性
- 单中心回顾性研究,样本量小(32例),结果需更大样本验证。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Obese individuals suffering from advanced chronic kidney disease (CKD) may be precluded from accessing kidney transplantation. Bariatric surgery is an effective treatment for obesity and related conditions but its use in those with severe CKD remains limited due to morbidity concerns. We aimed to evaluate the safety and efficacy of sleeve gastrectomy (SG) in patients with severe CKD as a bridging strategy towards kidney transplant candidacy. METHODS: This is a single-center retrospective study of a prospectively collected database of obese patients referred by the multi-organ transplant team for surgical weight loss, who underwent SG during 2013-2018. The primary outcome was 90-day major morbidity. Secondary outcomes included weight loss, and successful kidney transplantation. Descriptive statistics are expressed as count (percent) or median (interquartile range). RESULTS: 32 patients met inclusion criteria. 18 (56%) were male with a median age and BMI of 51 (11) years and 42.3 (5.2) kg/m2, respectively. 29 (91%) patients were on dialysis for a median duration of 28 months before SG. Diabetes, hypertension, and dyslipidemia were present in 15 (47%), 25 (78%), and 21 (66%) patients, respectively. At 90 days after SG, there were no leaks, reoperations, or mortality. The median length of stay was 2 (1.3) days. At 1 year, change in BMI and percent excess weight loss (EWL) were -9.8 (3.7) kg/m2 and 56% (27), respectively. In the year after SG, 20 (63%) patients were listed for transplant. 14 (44%) underwent successful kidney transplantation. One patient died while waiting for transplant. At time of transplant, median change in BMI and EWL were -9.0 (5.5) kg/m2 and 59% (30), respectively. After transplant, no patient required dialysis at a median follow-up of 17 (32) months. CONCLUSION: SG is safe and effective for weight loss and bridging to candidacy for kidney transplantation in patients with severe CKD. The acceptable safety and efficiency of SG in this high-risk population makes it an optimal choice as a bridging procedure.
引用
- Bouchard P, Tchervenkov J, Demyttenaere S, et al. Safety and efficacy of the sleeve gastrectomy as a strategy towards kidney transplantation. Surg Endosc. 2019. PMID: 31367986. doi:10.1007/s00464-019-07042-z
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。